These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 29021233)

  • 1. Divergent Activity of the Pseudogene
    Yndestad S; Austreid E; Skaftnesmo KO; Lønning PE; Eikesdal HP
    Mol Cancer Res; 2018 Jan; 16(1):78-89. PubMed ID: 29021233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
    Kerwin J; Khan I;
    Elife; 2020 Apr; 9():. PubMed ID: 32314732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA PTENP1/miR-21/PTEN Axis Modulates EMT and Drug Resistance in Cancer: Dynamic Boolean Modeling for Cell Fates in DNA Damage Response.
    Gupta S; Silveira DA; Lorenzoni PR; Mombach JCM; Hashimoto RF
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN regulates expression of its pseudogene in glioblastoma cells in DNA methylation-dependent manner.
    Kovalenko TF; Yadav B; Anufrieva KS; Larionova TD; Aksinina TE; Latyshev YA; Bastola S; Shakhparonov MI; Pandey AK; Pavlyukov MS
    Biochimie; 2024 Apr; 219():74-83. PubMed ID: 37619809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer.
    Scherer SD; Riggio AI; Haroun F; DeRose YS; Ekiz HA; Fujita M; Toner J; Zhao L; Li Z; Oesterreich S; Samatar AA; Welm AL
    Breast Cancer Res; 2021 Oct; 23(1):100. PubMed ID: 34717714
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Travis G; McGowan EM; Simpson AM; Marsh DJ; Nassif NT
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN insufficiency modulates ER+ breast cancer cell cycle progression and increases cell growth in vitro and in vivo.
    Chiang KC; Chen HY; Hsu SY; Pang JH; Wang SY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Sun CC; Lee JM; Yeh CN; Juang HH
    Drug Des Devel Ther; 2015; 9():4631-8. PubMed ID: 26316702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of lncRNA PTENP1 in tumorigenesis and progression of bladder cancer and the molecular mechanism].
    Yu G; Ou ZY; Tao QY; Wan GY; Lu ZH; Lang B
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1494-1500. PubMed ID: 29180330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTENP1 is a ceRNA for PTEN: it's CRISPR clear.
    Vitiello M; Evangelista M; Zhang Y; Salmena L; Pandolfi PP; Poliseno L
    J Hematol Oncol; 2020 Jun; 13(1):73. PubMed ID: 32517731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PTENP1 Pseudogene, Unlike the PTEN Gene, Is Methylated in Normal Endometrium, As Well As in Endometrial Hyperplasias and Carcinomas in Middle-Aged and Elderly Females.
    Kovalenko TF; Morozova KV; Ozolinya LA; Lapina IA; Patrushev LI
    Acta Naturae; 2018; 10(1):43-50. PubMed ID: 29713518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer.
    Elsarraj HS; Valdez KE; Hong Y; Grimm SL; Ricci LR; Fan F; Tawfik O; May L; Cusick T; Inciardi M; Redick M; Gatewood J; Winblad O; Hilsenbeck S; Edwards DP; Hagan CR; Godwin AK; Fabian C; Behbod F
    Cancer Res; 2017 Jul; 77(14):3802-3813. PubMed ID: 28515148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN expression can be used as a switch between senescence and apoptosis in breast cancer cells according to a logical model of the G2/M checkpoint.
    Marcello YMB; Silveira DA; Gupta S; Mombach JCM
    Biosystems; 2024 Jan; 235():105097. PubMed ID: 38065398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin alters distinct molecular pathways in breast cancer subtypes revealed by integrated miRNA/mRNA expression analysis.
    Nirgude S; Desai S; Choudhary B
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1596. PubMed ID: 34981672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining Cancer Subpopulations by Adaptive Strategies Rather Than Molecular Properties Provides Novel Insights into Intratumoral Evolution.
    Ibrahim-Hashim A; Robertson-Tessi M; Enriquez-Navas PM; Damaghi M; Balagurunathan Y; Wojtkowiak JW; Russell S; Yoonseok K; Lloyd MC; Bui MM; Brown JS; Anderson ARA; Gillies RJ; Gatenby RA
    Cancer Res; 2017 May; 77(9):2242-2254. PubMed ID: 28249898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of PTEN-Null Breast Cancer by a Synthetic Lethal Approach Involving PARP1 Gene Silencing.
    Asai T; Yokota M; Isomura H; Koide H; Sakurai N; Okamoto A; Ando H; Dewa T; Oku N
    J Pharm Sci; 2023 Jul; 112(7):1908-1914. PubMed ID: 36828124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A black phosphorus nanosheet-based RNA delivery system for prostate cancer therapy by increasing the expression level of tumor suppressor gene PTEN via CeRNA mechanism.
    Su S; Liu L; Fu Q; Ma M; Yang N; Pan T; Geng S; Yu XF; Zhu J
    J Nanobiotechnology; 2024 Jul; 22(1):391. PubMed ID: 38965509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoding breast cancer tissue-stroma interactions using species-specific sequencing.
    Chivukula IV; Ramsköld D; Storvall H; Anderberg C; Jin S; Mamaeva V; Sahlgren C; Pietras K; Sandberg R; Lendahl U
    Breast Cancer Res; 2015 Aug; 17(1):109. PubMed ID: 26265142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: PTENP1/miR-20a/PTEN axis contributes to breast cancer progression by regulating PTEN via PI3K/AKT pathway.
    Gao X; Qin T; Mao J; Zhang J; Fan S; Lu Y; Sun Z; Zhang Q; Song B; Li L
    J Exp Clin Cancer Res; 2023 Aug; 42(1):202. PubMed ID: 37559148
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line.
    Perez-Lanzon M; Maiuri MC; Lopez-Otin C; Kroemer G
    Genes Immun; 2024 Apr; 25(2):172-174. PubMed ID: 38218998
    [No Abstract]   [Full Text] [Related]  

  • 20. LncRNA PTENP1 inhibits cervical cancer progression by suppressing miR-106b.
    Fan Y; Sheng W; Meng Y; Cao Y; Li R
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):393-407. PubMed ID: 31913710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.